Your browser doesn't support javascript.
loading
Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy.
D'Addona, Matteo; Pezzullo, Luca; Giudice, Valentina; Serio, Bianca; Baldi, Carlo; Zeppa, Pio; Selleri, Carmine.
Afiliación
  • D'Addona M; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
  • Pezzullo L; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
  • Giudice V; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
  • Serio B; Department of Medicine, Surgery, and Dentistry University of Salerno Baronissi Italy.
  • Baldi C; Hematology and Transplant Center University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
  • Zeppa P; Anatomy Pathology University Hospital "San Giovanni di Dio e Ruggi d'Aragona" Salerno Italy.
  • Selleri C; Department of Medicine, Surgery, and Dentistry University of Salerno Baronissi Italy.
Clin Case Rep ; 10(6): e05919, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35677856
ABSTRACT
Kaposi's sarcoma is associated with immunosuppression and human herpesvirus 8 infection, while rarely described in myeloid malignancies. Here, we illustrate a rare case of chronic myeloid leukemia treated with imatinib, a tyrosine kinase inhibitor, who developed a human herpesvirus 8-related Kaposi's sarcoma.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article